Tumor Biology · 2016 · 36 citations · 28 references
MedicineOncologyPharmacologyCell SignalingChemotherapyMolecular OncologyBiliary Tract CancerCancer Cell SignalingCancer MetabolismChemotherapy ResistanceMalignant NeoplasmsAntiproliferative AgentsCancer Cell Proliferation InhibitionMolecular Drug ResistanceNrf2 Pathway ActivationNrf2 Signaling PathwayNrf2-mediated Cytoprotective SignalingNrf2-mediated ResponsesNuclear Factor Erythroid 2-Related Factor 2 Signaling
28
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer
Juan W. Valle, Harpreet Wasan, Daniel H. Palmer et al. · New England Journal of Medicine · 2010 · 4.4K citations · Full text
Medicine, Oncology, Pharmacology +12
Clonogenic assay of cells in vitro
Nicolaas A.P. Franken, Hans M. Rodermond, Jan Stap et al. · Nature Protocols · 2006 · 4.2K citations
Nrf2 Redirects Glucose and Glutamine into Anabolic Pathways in Metabolic Reprogramming
Yoichiro Mitsuishi, Keiko Taguchi, Yukie Kawatani et al. · Cancer Cell · 2012 · 1.4K citations · Full text
Nrf2 enhances resistance of cancer cells to chemotherapeutic drugs, the dark side of Nrf2
X.-J. Wang, Zheng Sun, Nicole Villeneuve et al. · Carcinogenesis · 2008 · 842 citations · Full text